Drug Shortage Report for INDIUM DTPA IN 111

Last updated on 2023-03-18 History
Report ID 186110
Drug Identification Number 02329093
Brand name INDIUM DTPA IN 111
Common or Proper name Pentetate Indium Disodium In 111 Injection
Company Name GE HEALTHCARE CANADA INC
Market Status MARKETED
Active Ingredient(s) PENTETATE INDIUM DISODIUM IN 111
Strength(s) 37MBq
Dosage form(s) SOLUTION
Route of administration INTRATHECAL INTRATHECAL
Packaging size 1.5 mL
ATC code V09AX
ATC description
Reason for shortage Other (Please describe in comments)
Anticipated start date
Actual start date 2023-03-03
Estimated end date 2023-03-17
Actual end date 2023-03-17
Shortage status Resolved
Updated date 2023-03-18
Company comments Manufacturing issues
Health Canada comments
Tier 3 Status No
Contact Address 1919 MINNESOTA COURT
MISSISSAUGA, ONTARIO
CANADA L5N 0C9
Company contact information 800-387-7146 canadainfo@ge.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v8 2023-03-18 English Compare
v7 2023-03-17 French Compare
v6 2023-03-17 English Compare
v5 2023-03-08 French Compare
v4 2023-03-08 English Compare
v3 2023-03-04 English Compare
v2 2023-03-03 French Compare
v1 2023-03-03 English Compare

Showing 1 to 8 of 8